Emergent BioSolutions Inc.

Verified identity

Start with the filing record

The identity and ticker come from the SEC’s official company ticker mapping. Market and editorial coverage are not inferred from that record.

Ticker: EBS
CIK: 0001367644
Exchange: NYSE
Universe updated: 2026-08-22

Open SEC filings

Market price

Latest quoteOpens Google

TickerGrove coverage

Latest on Emergent BioSolutions Inc.

Companies / Leadership change

Emergent BioSolutions CFO Richard Lindahl to retire Dec. 31; Frank Vargo named interim CFO

Lindahl steps down as principal financial and accounting officer on December 31, 2026; Frank Vargo becomes interim CFO on January 1, 2027 with an extra $3,850 per pay period on a $328,000 base salary.

Published 10-17-2026 · Emergent BioSolutions Inc.

Research foundation

Read the filing with the right frame

Company analysis

Revenue, EPS and guidance answer different earnings questions

Revenue is the top-line amount recognized from a company’s activities under its accounting policy.

Earnings reading room →

Company analysis

The three financial statements describe one business from different angles

The income statement records revenue and expenses over a period.

Company research desk →

Investing basics

Stocks, ETFs and indexes are different objects

A stock is an ownership interest in one company.

Company research desk →